MDxHealth SA (MDXH)
NASDAQ: MDXH · IEX Real-Time Price · USD
2.270
-0.090 (-3.81%)
At close: Jul 2, 2024, 3:59 PM
2.260
-0.010 (-0.44%)
After-hours: Jul 2, 2024, 4:44 PM EDT
MDxHealth Revenue
MDxHealth had revenue of $75.33M in the twelve months ending March 31, 2024, with 65.02% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $19.83M with 34.93% year-over-year growth. In the year 2023, MDxHealth had annual revenue of $70.19M with 89.43% growth.
Revenue (ttm)
$75.33M
Revenue Growth
+65.02%
P/S Ratio
0.82
Revenue / Employee
$251,090
Employees
300
Market Cap
61.94M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70.19M | 33.14M | 89.43% |
Dec 31, 2022 | 37.05M | 14.82M | 66.62% |
Dec 31, 2021 | 22.24M | 3.78M | 20.47% |
Dec 31, 2020 | 18.46M | 6.68M | 56.64% |
Dec 31, 2019 | 11.79M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Burning Rock Biotech | 72.30M |
Theratechnologies | 57.85M |
Pro-Dex | 49.46M |
Hyperfine | 11.69M |
Nutriband | 2.02M |
Ovid Therapeutics | 473.54K |
Genelux | 8.00K |
MDXH News
- 6 weeks ago - Mdxhealth to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed - GlobeNewsWire
- 4 months ago - Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering - GlobeNewsWire
- 4 months ago - Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results - GlobeNewsWire
- 4 months ago - MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 - GlobeNewsWire
- 4 months ago - Mdxhealth Announces Resignation of Board Member - GlobeNewsWire
- 6 months ago - MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance - GlobeNewsWire
- 7 months ago - MDxHealth Announces Completion of Transition to Single Listing on Nasdaq - GlobeNewsWire